Evidence map›Paper›PMID 32070465›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2020

First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020.

Sibylle Bernard Stoecklin, Patrick Rolland, Yassoungo Silue, Alexandra Mailles, Christine Campese, Anne Simondon, Matthieu Mechain, Laure Meurice, Mathieu Nguyen, Clément Bassi and 14 more

Registry-linked trialAbstract readCase Reports
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04470648 (COVID-19 Infection at Samusocial in Paris), which is not on this map. Cited by 276 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
276citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04470648 completednot on this map

COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey

TypeobservationalSponsorInstitut National de la Santé Et de la Recherche Médicale, FranceRan2020 to 2021Enrolled179ConditionsSARS-COV2 InfectionArmsblood test for SARS-COV2 serology
3 · Its place in the literature

Who cites it

276 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Article
  10. Social inequalities in COVID-19-related years of life lost in metropolitan France, 2020.Archives of public health = Archives belges de sante publique · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational

216 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Sibylle Bernard StoecklinSanté publique France, Direction des maladies infectieuses, Saint-Maurice, France.
Patrick RollandSanté publique France, Direction des régions, Saint-Maurice, France.
Yassoungo SilueSanté publique France, Direction des régions, Cellule Régionale Ile-de-France, Paris, France.
Alexandra MaillesSanté publique France, Direction des maladies infectieuses, Saint-Maurice, France.
Christine CampeseSanté publique France, Direction des maladies infectieuses, Saint-Maurice, France.
Anne SimondonAgence Régionale de Santé Ile-de-France, Paris, France.
Matthieu MechainAgence Régionale de Santé Nouvelle-Aquitaine, Bordeaux, France.
Laure MeuriceSanté publique France, Direction des régions, Cellule Régionale Nouvelle-Aquitaine, Bordeaux, France.
Mathieu NguyenAgence Régionale de Santé Nouvelle-Aquitaine, Bordeaux, France.
Clément BassiSanté publique France, Direction des régions, Cellule Régionale Ile-de-France, Paris, France.
Estelle YamaniAgence Régionale de Santé Ile-de-France, Paris, France.
Sylvie BehillilCentre National de Référence des virus des infections respiratoires, dont la grippe, Institut Pasteur, Paris, France.
Sophie IsmaelAP-HP, Hôpital Bichat, Service des maladies infectieuses et tropicales, Paris, France.
Duc NguyenCentre Hospitalier Universitaire de Bordeaux, Service des maladies infectieuses et tropicales, Bordeaux GeoSentinel Site, Bordeaux, France.
Denis MalvyUMR 1219, Université de Bordeaux, Bordeaux, France.
François Xavier LescureUniversité de Paris, IAME, INSERM, Paris, France.
Scarlett GeorgesSanté publique France, Direction des maladies infectieuses, Saint-Maurice, France.
Clément LazarusDirection Générale de la Santé, Ministère des solidarités et de la santé, Centre opérationnel de réception et de régulation des urgences sanitaires et sociales, Paris, France.
Anouk TabaïSanté publique France, Direction alerte et crise, Saint-Maurice, France.
Morgane StempfeletSanté publique France, Direction alerte et crise, Saint-Maurice, France.
Vincent EnoufCentre National de Référence des virus des infections respiratoires, dont la grippe, Institut Pasteur, Paris, France.
Bruno CoignardSanté publique France, Direction des maladies infectieuses, Saint-Maurice, France.
Daniel Levy-BruhlSanté publique France, Direction des maladies infectieuses, Saint-Maurice, France.
Investigation teamThe members of the investigation team are listed at the end of the article.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) causing a cluster of respiratory infections (coronavirus disease 2019, COVID-19) in Wuhan, China, was identified on 7 January 2020. The epidemic quickly disseminated from Wuhan and as at 12 February 2020, 45,179 cases have been confirmed in 25 countries, including 1,116 deaths. Strengthened surveillance was implemented in France on 10 January 2020 in order to identify imported cases early and prevent secondary transmission. Three categories of risk exposure and follow-up procedure were defined for contacts. Three cases of COVID-19 were confirmed on 24 January, the first cases in Europe. Contact tracing was immediately initiated. Five contacts were evaluated as at low risk of exposure and 18 at moderate/high risk. As at 12 February 2020, two cases have been discharged and the third one remains symptomatic with a persistent cough, and no secondary transmission has been identified. Effective collaboration between all parties involved in the surveillance and response to emerging threats is required to detect imported cases early and to implement adequate control measures.

Indexed as

Contact TracingCoronavirus InfectionsInfection ControlPneumonia, ViralPopulation SurveillanceAdultBetacoronavirusChinaCOVID-19FranceHumansMaleMiddle AgedRisk AssessmentSARS-CoV-2Travelcontact tracingcontainmentcoronavirusCOVID-19, SARS-CoV-2, 2019-nCovFranceSurveillance

Identifiers

PMID32070465
PMCPMC7029452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.